These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25006521)

  • 1. Prevalence and Genetic Characterization of Carbapenem- and Polymyxin-Resistant Acinetobacter baumannii Isolated from a Tertiary Hospital in Terengganu, Malaysia.
    Lean SS; Suhaili Z; Ismail S; Rahman NI; Othman N; Abdullah FH; Jusoh Z; Yeo CC; Thong KL
    ISRN Microbiol; 2014; 2014():953417. PubMed ID: 25006521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin Resistance Among XDR ST1 Carbapenem-Resistant
    Carrasco LDM; Dabul ANG; Boralli CMDS; Righetto GM; Carvalho ISE; Dornelas JV; Martins da Mata CPS; de Araújo CA; Leite EMM; Lincopan N; Camargo ILBDC
    Front Microbiol; 2021; 12():622704. PubMed ID: 33897637
    [No Abstract]   [Full Text] [Related]  

  • 3. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients.
    Haeili M; Kafshdouz M; Feizabadi MM
    Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and molecular mechanisms of colistin resistance in Acinetobacter baumannii clinical isolates in Tehran, Iran.
    Khoshbayan A; Shariati A; Shahmoradi S; Baseri Z; Mozafari H; Darban-Sarokhalil D
    Acta Microbiol Immunol Hung; 2021 Aug; ():. PubMed ID: 34370684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Genomics of Two ST 195 Carbapenem-Resistant Acinetobacter baumannii with Different Susceptibility to Polymyxin Revealed Underlying Resistance Mechanism.
    Lean SS; Yeo CC; Suhaili Z; Thong KL
    Front Microbiol; 2015; 6():1445. PubMed ID: 26779129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoters of Colistin Resistance in
    Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F
    Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymyxin B Heteroresistance and Adaptive Resistance in Multidrug- and Extremely Drug-Resistant Acinetobacter baumannii.
    Genteluci GL; de Souza PA; Gomes DBC; Sousa VS; de Souza MJ; Abib JRL; de Castro EAR; Rangel K; Villas Bôas MHS
    Curr Microbiol; 2020 Sep; 77(9):2300-2306. PubMed ID: 32494882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii.
    Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG
    Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of colistin resistance among carbapenem-resistant
    Abdulzahra AT; Khalil MAF; Elkhatib WF
    New Microbes New Infect; 2018 Nov; 26():53-58. PubMed ID: 30224972
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant
    Ilsan NA; Lee YJ; Kuo SC; Lee IH; Huang TW
    Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34198665
    [No Abstract]   [Full Text] [Related]  

  • 12. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.
    Arroyo LA; Herrera CM; Fernandez L; Hankins JV; Trent MS; Hancock RE
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3743-51. PubMed ID: 21646482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe.
    Goic-Barisic I; Music MS; Drcelic M; Tuncbilek S; Akca G; Jakovac S; Tonkić M; Hrenovic J
    J Glob Antimicrob Resist; 2023 Jun; 33():26-30. PubMed ID: 36878462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
    Moffatt JH; Harper M; Harrison P; Hale JD; Vinogradov E; Seemann T; Henry R; Crane B; St Michael F; Cox AD; Adler B; Nation RL; Li J; Boyce JD
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4971-7. PubMed ID: 20855724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM; Brown RM; Ashcraft DS; Pankey GA
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Mechanisms of Carbapenem Resistance Among
    Benmahmod AB; Said HS; Ibrahim RH
    Microb Drug Resist; 2019 May; 25(4):480-488. PubMed ID: 30394846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.